Publications

Review Article

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

Measuring Human Immunity

2017

Authors:

Gnjatic S, Bronte V, Brunet LR, Butler MO, Disis ML, Galon J, Hakansson LG, Hanks BA, Karanikas V, Khleif SN, Kirkwood JM, Miller LD, Schendel DJ, Tanneau I, Wigginton JM, Butterfield LH.

Journal:

Journal of Immunotherapy of cancer

Volume:

5

Page:

44

Pubmed:

Review Article

Expanding assessments of translational research programs: supplementing metrics with value judgments

Measuring Human Immunity

2013

Authors:

Scott, C.S., Nagasawa, P., Disis, M.L., Ramsey, B.W., Martin, P., Abernathy, N., Hacker, B.M., and Schwartz H.

Journal:

Evaluation and Health Professions

Volume:

37(1)

Page:

83-97

Pubmed:

Review Article

Immunologic biomarkers as correlates of clinical response to cancer immunotherapy

Measuring Human Immunity

2011

Authors:

Disis, M.L..

Journal:

Cancer Immunology Immunotherapy

Volume:

60(3)

Page:

433-43

Pubmed:

Review Article

ELISpot for measuring human immune responses to vaccines

Measuring Human Immunity

2011

Authors:

Slota M, Lim JB, Dang Y, Disis ML.

Journal:

Expert Review of Vaccine

Volume:

10(3)

Page:

299-306

Pubmed:

Original Article

Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer

Measuring Human Immunity

2009

Authors:

Dang Y and Disis ML

Journal:

Annals of the New York Academy of Sciences

Volume:

1174

Page:

81-7

Pubmed:

Original Article

An analytical workflow for investigating cytokine profiles

Measuring Human Immunity

2008

Authors:

Siebert JC, Inokuma M, Waid DM, Pennock ND, Vaitaitis GM, Disis ML, Dunne JF, Wagner DH and Maecker HT

Journal:

Cytometry A

Volume:

73(4)

Page:

289-98

Pubmed:

Methods

Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides

Measuring Human Immunity

2008

Authors:

Maecker HT, Hassler J, Payne JK, Summers A, Comatas K, Ghanayem M, Morse MA, Clay TM, Lyerly HK, Bhatia S, Ghanekar SA, Maino VC, delaRosa C and Disis ML

Journal:

BMC Immunology

Volume:

9

Page:

9

Pubmed:

Review Article

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

Measuring Human Immunity

2008

Authors:

Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Hakansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL Jr, Stroncek DF, StreicherH, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM.

Journal:

Journal of Translational Medicine

Volume:

6

Page:

81

Pubmed:

Methods

Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses

Measuring Human Immunity

2007

Authors:

Goodell V, dela Rosa C, Slota M, MacLeod B and Disis ML

Journal:

BMC Immunology

Volume:

8

Page:

21

Pubmed:

Original Article

Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors

Measuring Human Immunity

2007

Authors:

Ghanekar SA, Bhatia S, Ruitenberg JJ, delaRosa C, Disis ML, Maino VC, Maeker HT and Waters CA

Journal:

Journal of Immune Based Therapies and Vaccines

Volume:

5

Page:

7

Pubmed: